Current Sirna Targets in the Prevention and Treatment of Intimal Hyperplasia.

Leena Pradhan-Nabzdyk,Chenyu Huang,Frank W. Logerfo,Christoph S. Nabzdyk
2014-01-01
Abstract:Intimal hyperplasia (IH) is the leading cause of late vein and prosthetic bypass graft failure. Injury at the time of graft implantation leading to the activation of endothelial cells and dedifferentiation of vascular smooth muscle cells to a synthetic phenotype are known causes of IH. Prior attempts to develop therapy to mitigate these cellular changes to prevent IH and graft failure have failed. Small interfering RNA (siRNA) mediated targeted gene silencing is a promising tool to prevent IH. Several studies have been performed in this direction to target genes that are involved in IH. In this review we discuss siRNA targets that are being investigated for prevention and treatment of IH.
What problem does this paper attempt to address?